Payment overview · 2025
General Payments
$63,121.63
194 reported records · 25 companies
Healthcare provider profile · identity verified
Michael J Dorsi, MD
Allopathic & Osteopathic Physicians|Neurological Surgery · THOUSAND OAKS, CA · NPI 1942355854
Verified facts
What the public records show
CMS Open Payments records show Michael J Dorsi, MD received $63,121.63 in general payments during 2025 across 194 reported records.
Globus Medical, Inc. accounted for 34.7% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 45 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Globus Medical, Inc. | Unresolved — no canonical attribution shown | $21,903.49 | 34.7% | 124 | 2025 |
| Ferring Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $17,194.17 | 27.2% | 3 | 2025 |
| Saluda Medical Americas, Inc. | Unresolved — no canonical attribution shown | $9,168.68 | 14.5% | 6 | 2025 |
| BIOTRONIK NRO, Inc. | Unresolved — no canonical attribution shown | $8,352.60 | 13.2% | 21 | 2025 |
| The Institute of Musculoskeletal Science and Education | Unresolved — no canonical attribution shown | $3,571.48 | 5.7% | 1 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $1,050.12 | 1.7% | 9 | 2025 |
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $328.83 | 0.5% | 4 | 2025 |
| DePuy Synthes Sales Inc. | Unresolved — no canonical attribution shown | $222.57 | 0.3% | 4 | 2025 |
| SPR Therapeutics, Inc | Unresolved — no canonical attribution shown | $188.06 | 0.3% | 3 | 2025 |
| PAINTEQ LLC | Unresolved — no canonical attribution shown | $173.63 | 0.3% | 1 | 2025 |
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$172.26 | 0.3% | 3 | 2025 |
| Providence Medical Technology, Inc. | Unresolved — no canonical attribution shown | $132.59 | 0.2% | 2 | 2025 |
| SPINEOLOGY INC. | Unresolved — no canonical attribution shown | $98.65 | 0.2% | 1 | 2025 |
| Neo Spine USA, Inc. | Unresolved — no canonical attribution shown | $97.58 | 0.1% | 1 | 2025 |
| Intrinsic Therapeutics | Unresolved — no canonical attribution shown | $79.50 | 0.1% | 1 | 2025 |
| MML US, Inc. | Unresolved — no canonical attribution shown | $62.52 | 0.1% | 1 | 2025 |
| Carlsmed, Inc. | Unresolved — no canonical attribution shown | $61.84 | 0.1% | 1 | 2025 |
| Orthofix Medical, Inc. | Unresolved — no canonical attribution shown | $54.42 | 0.1% | 1 | 2025 |
| EBI, LLC | Unresolved — no canonical attribution shown | $43.02 | 0.1% | 1 | 2025 |
| Spineart USA Inc | Unresolved — no canonical attribution shown | $41.50 | 0.1% | 1 | 2025 |
| Nalu Medical, Inc. | Unresolved — no canonical attribution shown | $38.72 | 0.1% | 1 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $27.91 | 0.0% | 1 | 2025 |
| BIOTRONIK INC. | Unresolved — no canonical attribution shown | $23.30 | 0.0% | 1 | 2025 |
| Pacira Pharmaceuticals Incorporated | Unresolved — no canonical attribution shown | $20.13 | 0.0% | 1 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $14.06 | 0.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Consulting Fee | $39,172.50 | 9 |
| Food and Beverage | $9,171.46 | 159 |
| Compensation for serving as faculty or as a speaker for a medical education program | $6,806.25 | 3 |
| Travel and Lodging | $4,399.94 | 22 |
| Royalty or License | $3,571.48 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Evoke Normalized: evoke |
Device | Saluda Medical Americas, Inc. | $9,168.68 | 6 | 2025 |
Source payment records
|
|||||
| Prospera Normalized: prospera |
Device | BIOTRONIK INC., BIOTRONIK NRO, Inc. | $8,375.90 | 22 | 2025 |
Source payment records
|
|||||
| VYRSA V1 Normalized: vyrsa v1 |
Device | Globus Medical, Inc. | $7,258.64 | 12 | 2025 |
Source payment records
|
|||||
| Senza Normalized: senza |
Device | Globus Medical, Inc. | $5,363.61 | 43 | 2025 |
Source payment records
|
|||||
| ANTHEM Normalized: anthem |
Device | Globus Medical, Inc. | $4,500.00 | 2 | 2025 |
Source payment records
|
|||||
| Spira Normalized: spira |
Device | The Institute of Musculoskeletal Science and Education | $3,571.48 | 1 | 2025 |
Source payment records
|
|||||
| MODULUS Normalized: modulus |
Device | Globus Medical, Inc. | $1,645.67 | 6 | 2025 |
Source payment records
|
|||||
| EXCELSIUS GPS Normalized: excelsius gps |
Device | Globus Medical, Inc. | $1,565.30 | 25 | 2025 |
Source payment records
|
|||||
| PROCLAIM Normalized: proclaim |
Device | Abbott Laboratories | $944.16 | 7 | 2025 |
Source payment records
|
|||||
| SIMPLIFY CERVICAL ARTIFICIAL DISC Normalized: simplify cervical artificial disc |
Device | Globus Medical, Inc. | $412.79 | 12 | 2025 |
Source payment records
|
|||||
| General - Pain Management Normalized: general pain management |
Device | Boston Scientific Corporation | $278.73 | 3 | 2025 |
Source payment records
|
|||||
| SPRINT PNS System Normalized: sprint pns system |
Device | SPR Therapeutics, Inc | $188.06 | 3 | 2025 |
Source payment records
|
|||||
| SABLE Normalized: sable |
Device | Globus Medical, Inc. | $187.37 | 8 | 2025 |
Source payment records
|
|||||
| PAINTEQ Normalized: painteq |
Device | PAINTEQ LLC | $173.63 | 1 | 2025 |
Source payment records
|
|||||
| INCEPTIV Normalized: inceptiv |
Device | Medtronic, Inc. | $154.97 | 2 | 2025 |
Source payment records
|
|||||
| Velys Normalized: velys |
Device | DePuy Synthes Sales Inc. | $130.09 | 1 | 2025 |
Source payment records
|
|||||
| ETERNA Normalized: eterna |
Device | Abbott Laboratories | $105.96 | 2 | 2025 |
Source payment records
|
|||||
| OPTIMESH EXPANDABLE INTERBODY FUSION SYSTEM Normalized: optimesh expandable interbody fusion system |
Device | SPINEOLOGY INC. | $98.65 | 1 | 2025 |
Source payment records
|
|||||
| Neo Pedicle Screw System Normalized: neo pedicle screw system |
Device | Neo Spine USA, Inc. | $97.58 | 1 | 2025 |
Source payment records
|
|||||
| RELINE Normalized: reline |
Device | Globus Medical, Inc. | $96.49 | 3 | 2025 |
Source payment records
|
|||||
| TLIF Normalized: tlif |
Device | Globus Medical, Inc. | $90.24 | 2 | 2025 |
Source payment records
|
|||||
| BARRICAID ACD (ANNULAR CLOSURE DEVICE) Normalized: barricaid acd annular closure device |
Device | Intrinsic Therapeutics | $79.50 | 1 | 2025 |
Source payment records
|
|||||
| SYNTHECEL Normalized: synthecel |
Device | DePuy Synthes Sales Inc. | $75.22 | 2 | 2025 |
Source payment records
|
|||||
| XLIF Normalized: xlif |
Device | Globus Medical, Inc. | $70.69 | 1 | 2025 |
Source payment records
|
|||||
| ReActiv8 Normalized: reactiv8 |
Device | MML US, Inc. | $62.52 | 1 | 2025 |
Source payment records
|
|||||
| aprevo Normalized: aprevo |
Device | Carlsmed, Inc. | $61.84 | 1 | 2025 |
Source payment records
|
|||||
| RISE Normalized: rise |
Device | Globus Medical, Inc. | $61.73 | 1 | 2025 |
Source payment records
|
|||||
| OSSIFUSE Normalized: ossifuse |
Biological | Globus Medical, Inc. | $55.26 | 1 | 2025 |
Source payment records
|
|||||
| Spinal-Stim Normalized: spinal stim |
Device | Orthofix Medical, Inc. | $54.42 | 1 | 2025 |
Source payment records
|
|||||
| WaveWriter Alpha Prime 16 Normalized: wavewriter alpha prime 16 |
Device | Boston Scientific Corporation | $50.10 | 1 | 2025 |
Source payment records
|
|||||
| MATRIXNEURO Normalized: matrixneuro |
Device | DePuy Synthes Sales Inc. | $48.86 | 2 | 2025 |
Source payment records
|
|||||
| OMNIA Normalized: omnia |
Device | Globus Medical, Inc. | $48.46 | 1 | 2025 |
Source payment records
|
|||||
| OSTEOCEL Normalized: osteocel |
Biological | Globus Medical, Inc. | $45.79 | 1 | 2025 |
Source payment records
|
|||||
| BIOMET SPINALPAK NON-INVASIVE SPINE FUSION STIMULATOR SYSTEM Normalized: biomet spinalpak non invasive spine fusion stimulator system |
Device | EBI, LLC | $43.02 | 1 | 2025 |
Source payment records
|
|||||
| X-CORE Normalized: x core |
Device | Globus Medical, Inc. | $40.74 | 1 | 2025 |
Source payment records
|
|||||
| Nalu Neurostimulation System Normalized: nalu neurostimulation system |
Device | Nalu Medical, Inc. | $38.72 | 1 | 2025 |
Source payment records
|
|||||
| BOTOX Normalized: botox |
Biological | ABBVIE INC. | $27.91 | 1 | 2025 |
Source payment records
|
|||||
| QULIPTA Normalized: qulipta |
Drug | ABBVIE INC. | $27.91 | 1 | 2025 |
Source payment records
|
|||||
| INSTRUMENTS Normalized: instruments |
Device | Globus Medical, Inc. | $24.96 | 1 | 2025 |
Source payment records
|
|||||
| COHERE Normalized: cohere |
Device | Globus Medical, Inc. | $23.68 | 1 | 2025 |
Source payment records
|
|||||
| Exparel Normalized: exparel |
Drug | Pacira Pharmaceuticals Incorporated | $20.13 | 1 | 2025 |
Source payment records
|
|||||
| VANTA ADAPTIVESTIM Normalized: vanta adaptivestim |
Device | Medtronic, Inc. | $17.29 | 1 | 2025 |
Source payment records
|
|||||
| ACP Normalized: acp |
Device | Globus Medical, Inc. | $16.07 | 1 | 2025 |
Source payment records
|
|||||
| EVENITY Normalized: evenity |
Biological | Amgen Inc. | $14.06 | 1 | 2025 |
Source payment records
|
|||||
| PROLIA Normalized: prolia |
Biological | Amgen Inc. | $14.06 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $63,121.63 · 194 records | Globus Medical, Inc. | ACP, ANTHEM, BARRICAID ACD (ANNULAR CLOSURE DEVICE), BIOMET SPINALPAK NON-INVASIVE SPINE FUSION STIMULATOR SYSTEM, BOTOX, COHERE, ETERNA, EVENITY, EXCELSIUS GPS, Evoke, Exparel, General - Pain Management, INCEPTIV, INSTRUMENTS, MATRIXNEURO, MODULUS, Nalu Neurostimulation System, Neo Pedicle Screw System, OMNIA, OPTIMESH EXPANDABLE INTERBODY FUSION SYSTEM, OSSIFUSE, OSTEOCEL, PAINTEQ, PROCLAIM, PROLIA, Prospera, QULIPTA, RELINE, RISE, ReActiv8, SABLE, SIMPLIFY CERVICAL ARTIFICIAL DISC, SPRINT PNS System, SYNTHECEL, Senza, Spinal-Stim, Spira, TLIF, VANTA ADAPTIVESTIM, VYRSA V1, Velys, WaveWriter Alpha Prime 16, X-CORE, XLIF, aprevo | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error